삼성서울병원

Ko En

병리과 하상윤 교수

진료분야
간, 대장 병리
진료일정 11 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2014.08 성균관대학교 대학원 의학과 박사
2012.02 성균관대학교 대학원 의학과 석사
2005.02 성균관대학교 의과대학 의학사

경력

경력
2016.03 ~현재 성균관대학교 의과대학 병리학교실 조교수
2015.03 ~ 2016.02 삼성서울병원 병리과 임상전임강사
2013.03 ~ 2015.02 삼성서울병원 병리과 임상강사
2009.03 ~ 2013.02 삼성서울병원 병리과 레지던트
2008.05 ~ 2009.02 삼성서울병원 인턴
2005.03 ~ 2008.04 경북 안동시 공중보건의
  • RADIOLOGY 2020 10.1148/radiol.2020201940 Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma Min1, JH; Lee, MW; Park, HS; Lee, DH; Park, HJ; Lim, S; Choi, SY; Lee, J; Lee, JE; Ha, SY; Cha, DI; Carriere, KC; Ahn, JH
    View PubMed
  • CANCER GENOMICS PROTEOMICS 2020 10.21873/cgp.20229 Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma Cho1, YA; Choi, S; Park, S; Park, CK; Ha, SY
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-020-07378-4 Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas Min1, JH; Kim, SH; Hwang, JA; Hyun, SH; Ha, SY; Choi, SY; Kim, SW; Kim, HS
    View PubMed
  • J CANCER RES CLIN 2020 10.1007/s00432-020-03437-x Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma Ha1, SY; Yeo, SY; Lee, KW; Kim, SH
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-020-07438-9 Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI Min1, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2020.208 Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection Park1, S; Choi, S; Cho, YA; Sinn, DH; Kim, JM; Park, CK; Ha, SY
    View PubMed
  • J PATHOL CLIN RES 2020 10.1002/cjp2.179 Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis a direct comparison study in 153 gastric carcinomas Heo1, YJ; Lee, T; Byeon, SJ; Kim, EJ; Shin, HC; Kim, B; Kang, SY; Ha, SY; Kim, KM
    View PubMed
  • CANCERS 2020 10.3390/cancers12092395 Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter? Yoo1, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY
    View PubMed
  • CURR ONCOL 2020 10.3747/co.27.6163 Severe cytomegalovirus gastritis after pembrolizumab in a patient with melanoma Kim1, H; Ha, SY; Kim, J; Kang, M; Lee, J
    View PubMed
  • RADIOLOGY 2020 10.1148/radiol.2020192275 Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI A Multicenter Study Joo1, I; Kim, SY; Kang, TW; Kim, YK; Park, BJ; Lee, YJ; Choi, JI; Lee, CH; Park, HS; Lee, K; Kim, H; Yu, E; Kang, HJ; Ha, SY; Kim, JY; Ahn, S; Jung, ES; Kim, BH; Han, HS; Lee, JM
    View PubMed
  • PATHOL ONCOL RES 2020 10.1007/s12253-020-00871-7 Clinical Significance of Trk Receptor Expression as a New Therapeutic Target in Hepatocellular Carcinoma Choi1, S; Park, S; Cho, YA; Park, CK; Ha, SY
    View PubMed
  • VIRCHOWS ARCH 2020 10.1007/s00428-020-02841-5 Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma Ha1, SY; Choi, S; Park, S; Kim, JM; Choi, GS; Joh, JW; Park, CK
    View PubMed
  • IN VIVO 2020 10.21873/invivo.11930 Hepatic Angiosarcoma: Clinicopathologic Study With an Investigation of ROS1 Gene Rearrangements Jung1, H; Kim, HN; Jang, Y; Park, CK; Shin, SH; Ha, SY
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-019-06407-1 Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network Lee1, JH; Joo, I; Kang, TW; Paik, YH; Sinn, DH; Ha, SY; Kim, K; Choi, C; Lee, GW; Yi, JH; Bang, WC
    View PubMed
  • TRANSL ONCOL 2019 10.1016/j.tranon.2019.07.017 Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study Kwon1, D; Kim, B; Shin, HC; Kim, EJ; Ha, SY; Jang, KT; Kim, ST; Lee, J; Kang, WK; Park, JO; Kim, KM
    View PubMed
  • IN VIVO 2019 10.21873/invivo.11736 CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma Jung1, H; Kim, HN; Jang, Y; Park, CK; Ha, SY
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-50594-2 Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2019.152434 CCNE1 amplification is associated with liver metastasis in gastric carcinoma Kim1, B; Shin, HC; Heo, YJ; Ha, SY; Jang, KT; Kim, ST; Kang, WK; Lee, J; Kim, KM
    View PubMed
  • PATHOLOGY 2019 10.1016/j.pathol.2019.01.013 Gastrointestinal stromal tumour with CDKN2A deletions: a report of three cases Kim1, B; Ha, SY; Lee, S; Kim, KM
    View PubMed
  • J MOL DIAGN 2019 10.1016/j.jmoldx.2019.02.007 Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing A Direct Comparison Study with Immunohistochemistry Choi1, S; Chu, J; Kim, B; Ha, SY; Kim, ST; Lee, J; Kang, WK; Han, H; Sohn, I; Kim, KM
    View PubMed
  • ANTICANCER RES 2019 10.21873/anticanres.13435 Prognostic Role of Apelin Receptor Expression in Hepatocellular Carcinoma Treated With Curative Surgical Resection Lee1, T; Park, CK; Ha, SY
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-018-5642-5 Pre-operative ADC predicts early recurrence of HCC after curative resection Lee1, S; Kim, SH; Hwang, JA; Lee, JE; Ha, SY
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.013 Pathologic analyses of peritoneal nodules in gastric cancer patients during surgery-A single cancer center experience with diagnostic pitfalls Bae1, H; Kim, H; Chu, J; Jang, Y; Koh, HH; Jung, H; Ha, SY; Jang, KT; Kim, KM
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2018.10.024 The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma Cho1, J; Kim, KM; Kim, HC; Lee, WY; Kang, WK; Park, YS; Ha, SY
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.132 Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Lee1, SH; Lee, B; Shim, JH; Lee, KW; Md, JWY; Kim, SY; Kim, TY; Kim, YH; Ko, YH; Chung, HC; Yu, CS; Lee, J; Rha, SY; Kim, TW; Jung, KH; Im, SA; Moon, HG; Cho, S; Kang, JH; Kim, J; Kim, SK; Ryu, HS; Ha, SY; Il Kim, J; Chung, YJ; Kim, C; Kim, HL; Park, WY; Noh, DY; Park, K
    View PubMed
  • Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6 Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors Cha1, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I
    View PubMed
  • Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9 Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance Min1, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2018.04.007 Molecular Characterization of Colorectal Signet-Ring Cell Carcinoma Using Whole-Exome and RNA Sequencing Nam1, JY; Oh, BY; Hong, HK; Bae, JS; Kim, TW; Ha, SY; Park, D; Lee, WY; Kim, HC; Yun, SH; Park, YA; Joung, JG; Park, WY; Cho, YB
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-017-5248-3 Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival Min1, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I
    View PubMed
  • J HEPATOL 2018 10.1016/j.jhep.2018.01.024 Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ
    View PubMed
  • J GASTROEN HEPATOL 2018 10.1111/jgh.14035 Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis Pyo1, JH; Ha, SY; Hong, SN; Chang, DK; Son, HJ; Kim, KM; Kim, H; Kim, K; Kim, JE; Choi, YH; Kim, YH
    View PubMed
  • PATHOL RES PRACT 2018 10.1016/j.prp.2018.02.007 Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma Cho1, J; Ha, SY; Kim, SH; Sung, HH; Kwon, GY
    View PubMed
  • ACTA RADIOL 2018 10.1177/0284185117723040 Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging Han1, SB; Kim, YK; Min, JH; Ha, SY; Jeong, WK; Lee, WJ
    View PubMed
  • ANN SURG ONCOL 2018 10.1245/s10434-017-6135-5 Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study Oh1, BY; Park, YA; Huh, JW; Yun, SH; Kim, HC; Chun, HK; Kim, SH; Ha, SY; Lee, WY; Cho, YB
    View PubMed
  • J CUTAN PATHOL 2017 10.1111/cup.13006 CD13 is a marker for onychofibroblasts within nail matrix onychodermis: Comparison of its expression patterns in the nail unit and in the hair follicle Park1, JH; Lee, DY; Jang, KT; Ha, SY; Kwon, GY; Lee, KH; Shim, JS; Kwon, EJ
    View PubMed
  • HISTOPATHOLOGY 2017 10.1111/his.13292 Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases Kang1, G; Kang, Y; Kim, KH; Ha, SY; Kim, JY; Shim, YM; Heinrich, MC; Kim, KM; Corless, CL
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0185826 Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans Oh1, E; Jeong, HM; Kwon, MJ; Ha, SY; Park, HK; Song, JY; Kim, YJ; Choi, JS; Lee, EH; Lee, J; Choi, YL; Shin, YK
    View PubMed
  • EUR J RADIOL 2017 10.1016/j.ejard.2017.036 Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma Hwang1, JA; Kang, TW; Kim, YK; Kim, SH; Paik, YH; Ha, SY; Kim, S
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17941 Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance Yeo1, SY; Ha, SY; Lee, KW; Cui, Y; Yang, ZT; Xuan, YH; Kim, SH
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.18168 The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs Kim1, HK; Ha, SY; Lee, J; Park, SH; Park, JO; Lim, HY; Kang, WK; Park, YS; Kim, ST
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-12469-2 Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area Yu1, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC
    View PubMed
  • Abdom Radiol (NY) 2017 10.1007/s00261-017-1119-2 Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA Lee1, JH; Jeong, WK; Kim, YK; Lee, WJ; Ha, SY; Kim, KW; Kim, J
    View PubMed
  • EUR J RADIOL 2017 10.1016/j.ejrad.2017.04.008 Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum Min1, JH; Kim, YK; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Ahn, HS
    View PubMed
  • Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging Gu KW11, Kim YK2, Min JH1, Ha SY3, Jeong WK1.
    View PubMed
  • Cardiovasc Intervent Radiol. 2017 Mar;40(3):401-409. doi: 10.1007/s00270-016-1525-9. Epub 2016 Dec 8. Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications Kang TW11, Rhim H2, Song KD1, Lee MW1, Cha DI1, Ha SY3, Ahn JH4.
    View PubMed
  • Korean J Radiol. 2017 Jan-Feb;18(1):152-161. doi: 10.3348/kjr.2017.18.1.152. Epub 2017 Jan 5. Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance Kang TW11, Lee MW1, Song KD1, Kim M1, Kim SS1, Kim SH1, Ha SY2.
    View PubMed
  • Mod Pathol. 2017 Jan;30(1):4-14. doi: 10.1038/modpathol.2016.56. Epub 2016 Sep 30. Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression Son SM11, Ha SY1, Yoo HY2,3, Oh D4, Kim SJ3,5, Kim WS3,5, Ko YH1,3.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):2076-2082. doi: 10.18632/oncotarget.10502. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma Joung JG11, Ha SY2, Bae JS1, Nam JY1,3, Gwak GY4, Lee HO1,5, Son DS1,6, Park CK2, Park WY1,3,5.
    View PubMed
  • J Pathol. 2016 Nov;240(3):304-314. doi: 10.1002/path.4777. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis Min BH11, Hwang J2, Kim NK3, Park G2, Kang SY4, Ahn S4, Ahn S4, Ha SY4, Lee YK4, Kushima R5, Van Vrancken M6, Kim MJ7, Park C2, Park HY2,4, Chae J2, Jang SS2, Kim SJ8, Kim YH1, Kim JI9,10,11, Kim KM12.
    View PubMed
  • Transl Oncol. 2016 Oct;9(5):466-471. doi: 10.1016/j.tranon.2016.08.009. Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma Cho J11, Lee J1, Kim J1, Kim ST1, Lee S1, Kim SY1, Ha SY2, Park CK3, Lim HY4.
    View PubMed
  • Gut Liver. 2016 Sep 15;10(5):826-35. doi: 10.5009/gnl15543. NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy Ha SY11, Paik YH2, Yang JW1, Lee MJ1, Bae H1, Park CK1.
    View PubMed
  • Pathol Res Pract. 2016 Jul;212(7):616-21. doi: 10.1016/j.prp.2016.04.001. Epub 2016 Apr 7. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma Ha SY11, Kim JH2, Yang JW3, Bae H4, Cho HY5, Park CK6.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1065-73. doi: 10.4143/crt.2015.302. Epub 2015 Oct 16. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis Ha SY11, Kim JH2, Yang JW1, Kim J1, Kim B1, Park CK1.
    View PubMed
  • Medicine (Baltimore). 2016 May;95(19):e3534. doi: 10.1097/MD.0000000000003534. The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution Kim ST11, Ha SY, Lee J, Hong SN, Chang DK, Kim YH, Park YA, Huh JW, Cho YB, Yun SH, Lee WY, Kim HC, Park YS.
    View PubMed
  • Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4. Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival Kim M11, Kang TW2, Kim YK1, Kim SH1, Kwon W3, Ha SY4, Ji SA5.
    View PubMed
  • Am J Respir Cell Mol Biol. 2016 Feb;54(2):284-96. doi: 10.1165/rcmb.2014-0377OC. Mitochondrial E3 Ubiquitin Protein Ligase 1 Mediates Cigarette Smoke-Induced Endothelial Cell Death and Dysfunction Kim SY11, Kim HJ2, Park MK2, Huh JW3, Park HY4, Ha SY5, Shin JH2, Lee YS2.
    View PubMed
  • J Cancer. 2016 Feb 5;7(5):484-9. doi: 10.7150/jca.13711. eCollection 2016. The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs Kim ST11, Ha SY2, Lee S1, Ahn S2, Lee J1, Park SH1, Park JO1, Lim HY1, Kang WK1, Kim KM2, Park YS1.
    View PubMed
  • Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
    View PubMed
  • Oncotarget. 2016 Feb 16;7(7):7940-51. doi: 10.18632/oncotarget.6958. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients Choi HS11,2, Ha SY3, Kim HM1,2, Ahn SM3, Kang MS4,5, Kim KM3, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kang ES2.
    View PubMed
  • Oncotarget. 2016 Jan 26;7(4):4024-35. doi: 10.18632/oncotarget.6602. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors Park C11, Ha SY1, Kim ST2, Kim HC3, Heo JS3, Park YS2, Lauwers G4, Lee J2, Kim KM1.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):180-9. doi: 10.4143/crt.2014.321. Epub 2015 Mar 18. The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy Ha SY11, Choi M1, Lee T1, Park CK1.
    View PubMed
  • Pathol Res Pract. 2015 Dec;211(12):963-72. doi: 10.1016/j.prp.2015.10.001. Epub 2015 Oct 26. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups Kim Y11, Hong M1, Do IG1, Ha SY1, Lee D2, Suh YL3.
    View PubMed
  • Oncotarget. 2015 Nov 10;6(35):38372-80. doi: 10.18632/oncotarget.5368. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens Ahn S11,2, Ahn S1,3, Van Vrancken M1, Lee M1, Ha SY1, Lee H4, Min BH4, Lee JH4, Kim JJ4, Choi S5, Jung SH5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim KM1,3.
    View PubMed
  • Korean J Radiol. 2015 Nov-Dec;16(6):1253-6. doi: 10.3348/kjr.2015.16.6.1253. Epub 2015 Oct 26. Pancreatic Candidiasis That Mimics a Malignant Pancreatic Cystic Tumor on Magnetic Resonance Imaging: A Case Report in an Immunocompetent Patient Seong M11, Kang TW1, Ha SY2.
    View PubMed
  • Endocr J. 2015;62(10):857-77. doi: 10.1507/endocrj.EJ15-0234. Epub 2015 Jul 23. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis Yi JW11, Park JY, Sung JY, Kwak SH, Yu J, Chang JH, Kim JH, Ha SY, Paik EK, Lee WS, Kim SJ, Lee KE, Kim JH.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopatholoqical Analysis of 72 Cases in a Single Institute Shin Y11, Ha SY1, Hyeon J1, Lee B1, Lee J2, Jang KT1, Kim KM1, Park YS2, Park CK1.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):853-61. doi: 10.4143/crt.2014.177. Epub 2015 Feb 16. ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection Hwang HW11, Ha SY1, Bang H1, Park CK1.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):844-52. doi: 10.4143/crt.2014.124. Epub 2015 Feb 13. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma Bang H11, Ha SY1, Hwang SH1, Park CK1.
    View PubMed
  • J Clin Oncol. 2015 Aug 1;33(22):2450-6. doi: 10.1200/JCO.2014.59.9324. Epub 2015 Jun 29. Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial Sun JM11, Ahn JS1, Jung SH1, Sun J1, Ha SY1, Han J1, Park K1, Ahn MJ2.
    View PubMed
  • Cancer Res Treat. 2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17. Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck Noh JM11, Ha SY2, Ahn YC1, Oh D1, Seol SW1, Oh YL2, Han J2.
    View PubMed
  • Diagn Cytopathol. 2015 Jul;43(7):539-44. doi: 10.1002/dc.23242. Epub 2014 Nov 26. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations Song DH11, Lee B1, Shin Y1, Choi IH1, Ha SY1, Lee JJ1, Hong ME1, Choi YL1, Han J1, Um SW2.
    View PubMed
  • Oncotarget. 2015 Jul 30;6(21):18664-73. The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients Ha SY11, Sohn I2, Hwang SH1, Yang JW1, Park CK1.
    View PubMed
  • Genes Chromosomes Cancer. 2015 Jun;54(6):383-96. doi: 10.1002/gcc.22249. Epub 2015 Mar 31. Integrated Copy Number and Gene Expression Profiling Analysis of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Yoon H11, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH.
    View PubMed
  • Ann Dermatol. 2015 Apr;27(2):157-62. doi: 10.5021/ad.2015.27.2.157. Epub 2015 Mar 24. Identification of Leukocyte-Specific Protein 1-Positive Cells: A Clue to the Cell of Origin and a Marker for the Diagnosis of Dermatofibroma Jin SY11, Choi JS2, Choi YL3, Choi YL3, Kim do H1, Lee SH1.
    View PubMed
  • Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):171-7. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma Ha SY11, Song DH, Hwang SH, Cho SY, Park CK.
    View PubMed
  • Int J Cancer. 2015 Apr 1;136(7):1629-35. doi: 10.1002/ijc.29159. Epub 2014 Sep 4. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy Ha SY11, Lee J, Jang J, Hong JY, Do IG, Park SH, Park JO, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Kang WK, Kim KM.
    View PubMed
  • Oncotarget. 2015 Mar 10;6(7):5465-74. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR Ha SY11, Choi SJ2, Cho JH3, Choi HJ2, Lee J2, Jung K4, Irwin D5, Liu X6,7, Lira ME8, Mao M9, Kim HK3, Choi YS3, Shim YM3, Park WY10, Choi YL1,4,10, Kim J2,3.
    View PubMed
  • J Hepatol. 2015 Mar;62(3):556-62. doi: 10.1016/j.jhep.2014.10.027. Epub 2014 Oct 27. Microsteatosis may not interact with macrosteatosis in living donor liver transplantation Han S11, Ha SY2, Park CK2, Joh JW3, Kwon CH3, Kwon GY2, Kim G1, Gwak MS1, Jeong WK4, Ko JS5.
    View PubMed
  • Int J Clin Exp Pathol. 2015 Mar 1;8(3):3370-3. eCollection 2015. Nodular smooth muscle metaplasia in multiple peritoneal endometriosis Kim HS11, Yoon G2, Ha SY3, Song SY3.
    View PubMed
  • Oncotarget. 2014 Dec 15;5(23):12260-72. ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma Yeo SY11, Ha SY2, Yu EJ1, Lee KW1, Kim JH3, Kim SH4.
    View PubMed
  • Virchows Arch. 2014 Jan;464(1):19-27. doi: 10.1007/s00428-013-1504-3. Epub 2013 Nov 19. Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma Ha SY11, Kim KY, Lee NK, Kim MG, Kim SH.
    View PubMed